|
Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics |
|
|
|
Titel: |
Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics |
Auteur: |
Fudio, Salvador Sellers, Alvaro Pérez Ramos, Laura Gil-Alberdi, Beatriz Zeaiter, Ali Urroz, Mikel Carcas, Antonio Lubomirov, Rubin |
Verschenen in: |
Cancer, chemotherapy and pharmacology |
Paginering: |
Jaargang 90 () nr. 4 pagina's 285-299 |
Jaar: |
2022-08-27 |
Inhoud: |
|
Uitgever: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|